DYRK1A and Alzheimer disease: Therefore, the main purpose of this work is to develop local HQSAR models for a series of 6-arylquinazolin-4-amine inhibitors of DYRK1A [20,33], which may be used to design novel and potent derivatives as potential drugs for the treatment of AD.